Position in ARGX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$54,181,768
+$40,541,429 QoQ
Shares Held
58,400
+212.7% QoQ
Ownership
0.094%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#60
of 496 holders
Holding Since
Mar 2021
19 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Derivatives in ARGX
reported options exposure · as of Mar 31, 2026CallValue
$657,225
CallShares
900
PutValue
$4,016,375
PutShares
5,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Squarepoint Ops LLC holds $1,234,789,234 across 255 Biotechnology names. ARGX ranks #5 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
198,567 | $123,814,467 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
1,191,732 | $88,760,199 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
233,999 | $70,440,718 | |
| 4 | INSM |
INSMED Inc
|
616,464 | $65,727,391 | |
| 5 | ARGX |
Argenx SE
This page
|
58,400 | $54,181,768 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
422,921 | $46,956,918 | |
| 7 | APGE |
Apogee Therapeutics, Inc.
|
290,713 | $38,586,336 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
154,605 | $37,842,665 |
All Filings in ARGX
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $54,181,768 | 58,400 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $4,016,375 | 5,500 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $657,225 | 900 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $13,640,339 | 18,679 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $15,809,860 | 18,800 | Call | Defined | 2026-02-13 | |
| 2025-12-31 | $2,354,660 | 2,800 | Put | Defined | 2026-02-13 | |
| 2025-12-31 | $23,716,471 | 28,202 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $11,505,936 | 15,600 | Call | Defined | 2025-11-14 | |
| 2025-09-30 | $14,002,576 | 18,985 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $17,250,981 | 31,296 | Shares | Defined | 2025-08-27 | |
| 2025-06-30 | $9,756,594 | 17,700 | Call | Defined | 2025-08-27 | |
| 2025-03-31 | $18,005,125 | 30,421 | Shares | Defined | 2025-08-27 | |
| 2024-12-31 | $13,938,360 | 22,664 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $271,040 | 500 | Call | Defined | 2024-11-14 | |
| 2024-09-30 | $9,974,272 | 18,400 | Shares | Defined | 2024-11-14 | |
| 2024-09-30 | $379,456 | 700 | Put | Defined | 2024-11-14 | |
| 2024-06-30 | $17,843,219 | 41,492 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $10,974,551 | 27,874 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $6,999,912 | 18,400 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $436,567 | 888 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $353,874 | 908 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,486,594 | 3,990 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $4,732,635 | 13,405 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $688,046 | 1,816 | Shares | Defined | 2022-08-15 | |
| 2021-12-31 | $1,634,336 | 4,667 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,175,082 | 3,891 | Shares | Defined | 2021-11-15 | |
| 2021-03-31 | $500,383 | 1,817 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||